By Admin at 7 Nov 2016
A genetic test known as the 21-gene recurrence score assay (RS) measures the activity of genes that control cell growth and more. A high score on the test indicates a woman has a high risk of cancer recurrence and chemotherapy is recommended. A low score suggests chemotherapy can safely be skipped.
By Admin at 23 Aug 2016
A new chemotherapy drug has shown promise for treating both childhood and adult cancers with improvements above-and-beyond typical chemotherapy treatment. The treatment involves a novel class of antitumor amphiphilic amines (RCn).
By Admin at 6 May 2016
Chemobrain is often described as a mental fog that occurs during or after cancer treatment. New research shows, however, that not all chemotherapy drugs affect the brain the same way. In fact, one class of chemotherapy drugs used in the study was not related to chemobrain at all.
By Admin at 16 Mar 2016
A new discovery by researchers may help shed light on how chemotherapy works in each patient, as they’ve developed a way to track the treatment in real time.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial